Neurology

Investigators earn Michael J. Fox Foundation award


Investigators at UF’s Center for Translational Research in Neurodegenerative Disease, or CTRND, earned a one-year, $200,000 award from the Michael J. Fox Foundation’s Target Advancement Program to explore novel approaches to treat Parkinson’s disease.

The award will fund a study to determine how targeting cannabinoid receptor 2, or CB2, could alter the behavior of microglia that interact with alpha-synuclein, a protein that aggregates in Parkinson’s disease.

Source link

Related posts

5 Scary Ways Alcohol Damages the Brain

Newsemia

Development of the Central Africa Daily Functioning Interference Scale for Dementia Diagnosis in Older Adults: The EPIDEMCA Study.

Newsemia

Cannabidiol Wins FDA Review for Tuberous Sclerosis Complex

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World